OpenArc Corporate Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Buy
21,861
+1,809
+9% +$868K 0.13% 115
2026
Q1
$9.86M Buy
20,052
+1,482
+8% +$804K 0.14% 107
2025
Q4
$10.8M Buy
+18,570
New +$10.5M 0.18% 82

Other funds holding TMO

OpenArc Corporate Advisory's TMO Position: Q2 2026 in Review

OpenArc Corporate Advisory increased its Thermo Fisher Scientific (TMO) stake by 9% in Q2 2026, buying an estimated $868K and bringing the position to 21,861 shares worth $11M. The position accounts for 0.13% of the portfolio, ranked #115.

OpenArc Corporate Advisory first reported a position in TMO in Q4 2025 and has held it in 3 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • OpenArc Corporate Advisory held 21,861 shares of Thermo Fisher Scientific worth $11M as of Q2 2026.
  • OpenArc Corporate Advisory bought 1,809 Thermo Fisher Scientific shares in Q2 2026, an estimated $868K.
  • Thermo Fisher Scientific made up 0.13% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #115 holding.
  • OpenArc Corporate Advisory first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 3 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.